NO20005838L - Farmasöytisk multipartikkelform med programmert og styrt frigivning, samt fremstilling derav - Google Patents

Farmasöytisk multipartikkelform med programmert og styrt frigivning, samt fremstilling derav

Info

Publication number
NO20005838L
NO20005838L NO20005838A NO20005838A NO20005838L NO 20005838 L NO20005838 L NO 20005838L NO 20005838 A NO20005838 A NO 20005838A NO 20005838 A NO20005838 A NO 20005838A NO 20005838 L NO20005838 L NO 20005838L
Authority
NO
Norway
Prior art keywords
active principle
polymer
hours
programmed
manufacture
Prior art date
Application number
NO20005838A
Other languages
English (en)
Other versions
NO330501B1 (no
NO20005838D0 (no
Inventor
Edouard Gendrot
Gerard Cousin
Francoise Ragot
Marie-Christine Clee-Bouvet
Original Assignee
Prographarm Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prographarm Lab filed Critical Prographarm Lab
Publication of NO20005838D0 publication Critical patent/NO20005838D0/no
Publication of NO20005838L publication Critical patent/NO20005838L/no
Publication of NO330501B1 publication Critical patent/NO330501B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20005838A 1998-05-20 2000-11-17 Farmasoytisk multipartikkelform med forsinket og pulset frigivning, samt fremstilling derav NO330501B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9806384A FR2778848B1 (fr) 1998-05-20 1998-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation
PCT/FR1999/001201 WO1999059557A1 (fr) 1998-05-20 1999-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation

Publications (3)

Publication Number Publication Date
NO20005838D0 NO20005838D0 (no) 2000-11-17
NO20005838L true NO20005838L (no) 2001-01-10
NO330501B1 NO330501B1 (no) 2011-05-02

Family

ID=9526556

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005838A NO330501B1 (no) 1998-05-20 2000-11-17 Farmasoytisk multipartikkelform med forsinket og pulset frigivning, samt fremstilling derav

Country Status (25)

Country Link
EP (1) EP1077687B1 (no)
JP (1) JP2002515423A (no)
KR (1) KR100583065B1 (no)
CN (1) CN1186014C (no)
AT (1) ATE214598T1 (no)
AU (1) AU758299B2 (no)
BG (1) BG64764B1 (no)
BR (1) BR9910606A (no)
CA (1) CA2333188C (no)
DE (1) DE69901062T2 (no)
DK (1) DK1077687T3 (no)
ES (1) ES2173739T3 (no)
FR (1) FR2778848B1 (no)
GE (1) GEP20022750B (no)
HK (1) HK1033271A1 (no)
HU (1) HU224193B1 (no)
IL (1) IL139774A (no)
MX (1) MXPA00011364A (no)
NO (1) NO330501B1 (no)
NZ (1) NZ508392A (no)
PL (1) PL192950B1 (no)
PT (1) PT1077687E (no)
TR (1) TR200100107T2 (no)
WO (1) WO1999059557A1 (no)
ZA (1) ZA200006768B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ709754A (en) 2004-10-21 2017-02-24 Adare Pharmaceuticals Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
AU2013273835B2 (en) * 2005-05-02 2016-07-07 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008136016A1 (en) * 2007-05-08 2008-11-13 Medreich Limited A stable controlled release oral solid dosage form composition and a process thereof
KR101765357B1 (ko) 2009-12-02 2017-08-04 아데어 파마수티컬스 에스.알.엘. 펙소페나딘 마이크로캡슐 및 그것을 함유하는 조성물
FR2999432B1 (fr) 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
FR2754710B1 (fr) * 1996-10-22 1998-12-31 Prographarm Lab Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle

Also Published As

Publication number Publication date
EP1077687A1 (fr) 2001-02-28
CA2333188A1 (fr) 1999-11-25
AU3830299A (en) 1999-12-06
BG64764B1 (bg) 2006-03-31
DK1077687T3 (da) 2002-06-17
BG104963A (en) 2001-07-31
IL139774A0 (en) 2002-02-10
JP2002515423A (ja) 2002-05-28
GEP20022750B (en) 2002-08-26
HK1033271A1 (en) 2001-08-24
KR20010052370A (ko) 2001-06-25
AU758299B2 (en) 2003-03-20
HUP0102027A2 (hu) 2002-03-28
ZA200006768B (en) 2001-11-20
EP1077687B1 (fr) 2002-03-20
FR2778848B1 (fr) 2001-11-23
BR9910606A (pt) 2001-10-02
NO330501B1 (no) 2011-05-02
CA2333188C (fr) 2010-07-06
ATE214598T1 (de) 2002-04-15
ES2173739T3 (es) 2002-10-16
WO1999059557A1 (fr) 1999-11-25
CN1305371A (zh) 2001-07-25
CN1186014C (zh) 2005-01-26
NO20005838D0 (no) 2000-11-17
DE69901062D1 (de) 2002-04-25
FR2778848A1 (fr) 1999-11-26
MXPA00011364A (es) 2008-09-09
NZ508392A (en) 2002-09-27
IL139774A (en) 2005-09-25
TR200100107T2 (tr) 2001-06-21
PL344314A1 (en) 2001-10-22
KR100583065B1 (ko) 2006-06-08
PT1077687E (pt) 2002-09-30
PL192950B1 (pl) 2006-12-29
HUP0102027A3 (en) 2002-12-28
HU224193B1 (hu) 2005-06-28
DE69901062T2 (de) 2002-10-31

Similar Documents

Publication Publication Date Title
NO20005838D0 (no) Farmasöytisk multipartikkelform med programmert og styrt frigivning, samt fremstilling derav
WO2004035020A3 (en) Controlled release preparation
DK74187A (da) Praeparat til langsom frigivelse samt fremgangsmaade til fremstilling deraf
DE60036874D1 (de) Pellet formulierung mit gesteuerter freisetzung
CY1107695T1 (el) Μεθοδος παραγωγης επικαλυμμενων δισκιων με συγκαλυμμενη γευση και αμεση απελευθερωση του δραστικου παραγοντα
EP0650353A4 (en) PLEASANT TASTE PHARMACEUTICAL COMPOSITIONS.
AU2001239658A1 (en) Method for producing a controlled-release preparation
WO2004091530A3 (en) Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom
WO2001034119A3 (en) Inhibitors of crystallization in a solid dispersion
NO964410L (no) Matriks-pelleter med langsom frigiving, samt fremstilling av disse
KR950702409A (ko) 방출 조절 모르핀 제제(controlled release morphine preparation)
NO20001042D0 (no) Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter
DK1663217T3 (da) Faste dispersioner indeholdende tacrolimus
DK0729357T3 (da) Mikroindkapslede 1,2-benzazoler
CA2141582A1 (en) Pelletised pharmaceutical composition
AU4693485A (en) Sustained release drug in ter polymer coat (pvc and pvacand pvom)
WO2004066984A3 (en) Improved taste masking pharmaceutical composition and process for its preparation
DK1417960T3 (da) Mikropellets med vedvarende frisætning og fremgangsmåde til fremstilling heraf
PT744947E (pt) Composicoes de metronidazole com libertacao modificada e metodos para os fazer e utilizar
DK1227797T3 (da) Farmaceutiske faststofdispersionsformuleringer
WO2006006691A3 (en) Solid dispersion of a p38 map kinase inhibitor
Ward Jr et al. The effects of changes in dietary protein and water availability on urinary nitrogen compounds in the rooster, Gallus domesticus--II. Diurnal patterns in urine flow rates, and urinary uric acid and ammonia concentrations
TH61893C3 (th) องค์ประกอบทางเภสัชกรรมที่เคลือบเอนเทอริค และวิธีการผลิต
ES2004693A6 (es) Un procedimiento para la preparacion de una composicion farmaceutica solida administrable por via oral, que contiene vinburnina como principio activo.

Legal Events

Date Code Title Description
MK1K Patent expired